Literature DB >> 36034163

Quantile Markov Decision Processes.

Xiaocheng Li1, Huaiyang Zhong1, Margaret L Brandeau1.   

Abstract

The goal of a traditional Markov decision process (MDP) is to maximize expected cumulative reward over a defined horizon (possibly infinite). In many applications, however, a decision maker may be interested in optimizing a specific quantile of the cumulative reward instead of its expectation. In this paper we consider the problem of optimizing the quantiles of the cumulative rewards of a Markov decision process (MDP), which we refer to as a quantile Markov decision process (QMDP). We provide analytical results characterizing the optimal QMDP value function and present a dynamic programming-based algorithm to solve for the optimal policy. The algorithm also extends to the MDP problem with a conditional value-at-risk (CVaR) objective. We illustrate the practical relevance of our model by evaluating it on an HIV treatment initiation problem, where patients aim to balance the potential benefits and risks of the treatment.

Entities:  

Keywords:  Dynamic Programming; Markov Decision Process; Medical Decision Making; Quantile; Risk Measure

Year:  2021        PMID: 36034163      PMCID: PMC9401554          DOI: 10.1287/opre.2021.2123

Source DB:  PubMed          Journal:  Oper Res        ISSN: 0030-364X            Impact factor:   3.924


  10 in total

1.  Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

Authors:  Milton C Weinstein; Bernie O'Brien; John Hornberger; Joseph Jackson; Magnus Johannesson; Chris McCabe; Bryan R Luce
Journal:  Value Health       Date:  2003 Jan-Feb       Impact factor: 5.725

2.  High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa.

Authors:  Frank Tanser; Till Bärnighausen; Erofili Grapsa; Jaffer Zaidi; Marie-Louise Newell
Journal:  Science       Date:  2013-02-22       Impact factor: 47.728

3.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

4.  Quantile regression-opportunities and challenges from a user's perspective.

Authors:  Andreas Beyerlein
Journal:  Am J Epidemiol       Date:  2014-07-02       Impact factor: 4.897

5.  The use of quantile regression in health care research: a case study examining gender differences in the timeliness of thrombolytic therapy.

Authors:  Peter C Austin; Jack V Tu; Paul A Daly; David A Alter
Journal:  Stat Med       Date:  2005-03-15       Impact factor: 2.373

6.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

7.  Risk-attitude and patient treatment preferences.

Authors:  L Fraenkel; S T Bogardus; D R Wittink
Journal:  Lupus       Date:  2003       Impact factor: 2.911

8.  Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal?

Authors:  Diana M Negoescu; Douglas K Owens; Margaret L Brandeau; Eran Bendavid
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

9.  Health outcomes and cost-effectiveness of treating depression in people with HIV in Sub-Saharan Africa: a model-based analysis.

Authors:  Huaiyang Zhong; Isabel K Arjmand; Margaret L Brandeau; Eran Bendavid
Journal:  AIDS Care       Date:  2020-01-27

10.  HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan.

Authors:  Matthew S Freiberg; Kaku So-Armah
Journal:  J Am Heart Assoc       Date:  2016-03-24       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.